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Background: To summarize the diagnosis and treatment of cystic renal cell carcinoma (CRCC).
Methods: A retrospective study was conducted on 13 patients with CRCC at our center from August 2004 to April
2012. The pathologic features, clinical manifestation, imaging characteristics, treatment, and prognosis of CRCC were
summarized according to available literature.
Results: Of the 13 patients, 11 were diagnosed with CRCC by preoperative B ultrasonography and computed
tomography (CT) scan. The remaining two cases were initially misdiagnosed with simple renal cysts. Open radical
nephrectomy was performed on two of the 13 cases, laparoscopic radical nephrectomy on seven cases, and open
partial nephrectomy on four cases. All diagnoses of CRCC were confirmed by pathological examination. After the
operation, all patients had an uneventful recovery. During the follow-up (range, 6–60 months), the serum creatinine
concentrations and GFR of the partially removed kidneys remained stable within the normal range. No tumor
recurrence or metastasis occurred.
Conclusions: By combining imaging examinations (B ultrasonography and CT scan) with intraoperative
pathological examination, most cases of CRCC can be diagnosed and treated promptly and accurately.
Nephrectomy is the first-line therapy. Nephron-sparing surgery should be preferred for CRCC. After a successful
operation, the prognosis of CRCC is good.
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Cystic renal cell carcinoma (CRCC) is a special type of
renal cell carcinoma. It is relatively rare and involves
fluid-filled masses. The classification of cystic renal
disease is based on the Bosniak classification system
(Table 1) [1,2]. However, CRCC is usually misdiagnosed as
a benign renal cyst due to similar clinical manifestations
and imaging characteristics. In the present study, we retro-
spectively analyzed 13 cases with CRCC at our center and
summarize the pathologic features, clinical manifestation,
imaging characteristics, treatment, and prognosis of CRCC
according to available literature.
Methods
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Data were acquired from13 patients with CRCC (10 men
and threewomen) at our center from August 2004 and
April 2012. The mean age was 62 years (range, 35–74
years). Four patients were symptomatic. They showed flank
pain or discomfort (three cases) and indolent hematuria
(one case). Nine patients were asymptomatic. Their cystic
renal masses were accidentally found during health exami-
nations. All patients received B ultrasonography, computed
tomography (CT) scan, and preoperative serum creatinine
determination. Glomerular filtration rate (GFR) was
measured on cases preparing for partial nephrectomy.
The diagnoses were made according to the Bosniak
classification system.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 The Bosniak classification of renal cystic masses
Bosniak category Features Work-up
I A simple benign cyst with a hairline-thin wall that does not contain septa, calcification, or solid
components. It has the same density as water and does not enhance with contrast medium.
Benign
II A benign cyst that may contain a few hairline-thin septa. Fine calcification may be present in
the wall or septa. Uniformly high-attenuation lesions <3 cm in size, with sharp margins but
without enhancement.
Benign
IIF These cysts may contain more hairline-thin septa. Minimal enhancement of a hairline-thin
septum or wall can be seen. There may be minimal thickening of the septa or wall. The cyst
may contain calcification, which may be nodular and thick, but there is no contrast
enhancement. There are no enhancing soft-tissue elements. This category also includes totally
intrarenal, non-enhancing, highattenuation renal lesions ≥3 cm in size. These lesions are
generally well-marginated.
Follow-up. A small proportion
are malignant.
III These lesions are indeterminate cystic masses that have thickened irregular walls or septa in
which enhancement can be seen.
Surgery or follow-up. Over 50%
of the lesions are malignant.
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Patients with CRCC underwent open or laparoscopic
nephrectomy. Intraoperative frozen section analysis was
performed on every case. Cases with simple renal cysts
received laparoscopic renal cyst decortications.
Results
The preoperative serum creatinine concentration and
GFR were in normal range. Left renal cystic masses
were observed in eight patients. The remaining five
showed right renal cystic masses. Of the 13 patients,
ninemultilocularCRCC, one unilocular CRCC, and three
simple renal cysts were diagnosed using B ultrasonography
(Figure 1). After CT scanning (Figure 2), one ‘simple
renal cyst’ was diagnosed as unilocularCRCC. The mean
diameter of the masses was 6.2 cm (range, 3.6-8.5 cm). No
tumor metastasis was observed through preoperativeFigure 1 A typical B ultasonographic image of CRCC. The uneven cystiexaminations. According to the TNM staging system, all
patients were in the cT1-2N0M0 stage.
The 11 patients diagnosed with CRCC underwent neph-
rectomy, with one case of open radical nephrectomy, six
of laparoscopic radical nephrectomy, and four of open
partial nephrectomy. Intraoperative frozen section analysis
certified to preoperative diagnosis of CRCC. The two
patients diagnosed with simple renal cysts received
laparoscopic cyst decortication. During the operation,
dark red hydatid fluid and abnormal capsule walls
were observed in one case. Intraoperative frozen section
analysis of excised capsule walls suggested renal clear
cell carcinoma. The procedure was then changed to
laparoscopic radical nephrectomy. Postoperative pathology
confirmed the diagnosis of CRCC (clear cell carcinoma).
The final pathological result confirmed the diagnosis
of clear cell carcinoma, although no abnormalitiesc walls, hyperechoicsepa, and nodules were visible.
Figure 2 A typical CT scan image of a left kidney with CRCC. (A)The CT scan showed the thick and irregular capsule walls surrounding
several cysts with hyperdense septa and nodules. (B)The enhanced CT scan image showed the intense enhancements and calcification of capsule
walls, septa, and nodules. The debris, floc, and blood clots were also visible in the hydatid fluid.
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patient was readmitted for open radical nephrectomy 1
month later.
After operation, all patients had an uneventful recovery.
During the follow-up (range, 6–60 months), the serum
creatinine concentrations and GFR of the partially removed
kidneys remained stable within the normal range. No
tumor recurrence or metastasis occurred.
Discussion
Cystic degeneration of the kidney is very common in
renal lesions. About 50% of individuals aged >50 years
have cystic renal disease. However, CRCC is relatively
rare [3]. Accurate diagnosis and treatment are sometimes
difficult because CRCC and benign renal cystic disease have
similar clinical manifestations and imaging characteristics.
Here, we retrospectively analyzed 13 patients with CRCC at
our center and summarize the characteristics of CRCC
according to available literature. The information may
improve the diagnosis and treatment of this kind of disease.
Etiology and pathologic features of CRCC
The pathogenesis of CRCC remains unclear. Some
possible reasons are as follows. First, the tumor originates
from the epithelium of the proximal convoluted tubule
and grows in a cystic pattern. Then the cystic neoplasm
gradually forms mutually unintelligible cysts with different
sizes, containing hemorrhages and pseudo-capsules. This
kind of tumor is usually multilocularCRCC. Second, insuf-
ficient blood supply, hemorrhage, and necrosis of renal
cell carcinoma can lead to the formation of pseudocysts.
This kind of tumor is usually unilocularCRCC and shows
thick and irregular capsule walls. Third, the tumor origi-
nates from the epithelial cells of the cyst wall. The mass is
usually located in the base of the cyst. Lastly, the tumormay obstruct the kidney tubules and renal arterioles,
which can cause cysts to form. This kind of CRCC is
relatively rare. In the present study, nine cases were
found to be multilocular and four were unilocular.
Pathologically, the mass of CRCC usually has clear
boundaries and is composed of capsular cavities of different
sizes [4]. At the level of electron microscopy, clear cancer
cells and scar-like tissue can be observed. Cancer cells are
uniform in size and rare in mitotic figures, with low nuclear
grade (diploid or few aneuploidy) [4,5]. Cyst puncture
cytology examination can assist diagnosis through observ-
ing abnormal hydatid fluid and cells. However, the low
positive rate limits its use in clinical settings. Intraoperative
pathological examination is more accurate for diagnosis. In
our study, frozen section analysis not only confirmed the
preoperative imaging diagnosis of 11 cases with CRCC, but
also prevented misdiagnosis in one case. Our data suggest
that pathological examination is necessary for the diagnosis
and further treatment of CRCC, especially suspected cases.
Clinical manifestation of CRCC
The triad of hematuria, flank pain, and abdominal mass
is the classic symptoms of renal cell carcinoma, including
CRCC. However, only 10% of patients with renal cell car-
cinoma have all three signs. This often means that tumor is
in the advanced stage. The majority of patients with CRCC
are identified despite the absence of clinical symptoms. In
our study, nine asymptomatic patients with CRCC were
identified through routine physical examinations. Only four
patients showed typical symptoms.
Imaging characteristics of CRCC
B ultrasonography and CT scan are the main methods of
diagnosing CRCC [6,7]. Typical ultrasound images are as
follows: cystic echo-free masses with hyperechoic septa,
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several hyperechoic nodules attached to these septa. CT
scan can provide richer diagnostic information than
ultrasonography. It can show the thick and irregular
capsule walls surrounding the cysts with hyperdense septa
and nodules. In enhanced CT scan images, the capsule
walls, septa, and nodules show intense early enhancement.
In addition, coarse and crescent calcification is often
observed in the capsule walls, septa, and nodules. The septa
tend to be of uneven thickness (often >1 mm in diameter)
and nodular thickening can appear at the junctions to the
capsule walls. The hydatid fluid contains debris, floc, and
blood clots, which appear uneven on CT scan. The lesions
have unclear borders adjacent to renal parenchyma.
According to imaging features, most CRCC can be
diagnosed accurately. However, a few CRCC, especially
unilocularCRCC, have characteristics similar to those of
simple renal cysts. In the present study, two cases were
misdiagnosed as renal cysts.
Treatment of CRCC
Nephrectomy is the most effective treatment for CRCC
[8]. Coricaet al. compared several surgical approaches of
CRCC, including radical nephrectomy, simple nephrec-
tomy, partial nephrectomy, and tumor enucleation [9].
Their results showed the best approaches to be radical and
partial nephrectomy. It is now generally recognized that
localized renal cancers are best treated by nephron-sparing
surgery (partial nephrectomy). As long as the resection
margin of the tumor is negative, partial nephrectomy is
sufficient to avoid local recurrence. Nephron-sparing sur-
gery is particularly suitable for patients with contralateral
renal insufficiency or solitary kidneys. Recently, some new
concepts and techniques regarding partial nephrectomy
have been used to maximize the protection of renal func-
tion. In a series of studies, Simone et al. reported zero-
ischemia combination therapy of superselective arterial
embolization with partial nephrectomy to T1 renal carcin-
omas without hilar clamping [10,11]. In a recent study, they
also described the use of sutureless partial nephrectomy in
the treatment of small and exophytic renal carcinomas
without clamping hilar vessels and reconstructing the renal
parenchyma [12]. Gill et al. reported a novel approach to
facilitate zero-ischemia partial nephrectomy without hilar
clamping, in which tumor-specific or higher-order renal
arterial branches were microdissected and blocked using
neurosurgical aneurysm micro-bulldog clamps [13,14].
Intraparenchymal renal carcinomas could also be treated
by partial nephrectomy with the help of intraoperative
ultrasound guidance [15]. These developments reduced
ischemic renal damage, protected renal function, and
expanded the indications for partial nephrectomy.
However, because of the complexity of the procedure
involved, nephron-sparing surgery should be performed atwell-equipped centers by experienced personnel. Partial
nephrectomy began to be widely performed for renal
carcinoma at our center since 2008. In the present study,
most of the nine patients undergoing radical nephrectomy
were admitted before 2008 and had large renal mass. The
four cases receiving partial nephrectomy were admitted
after 2008 and had T1 stage. Open nephrectomy was the
gold standard treatment for CRCC. Recently, laparoscopic
nephrectomy and even robot-assisted nephrectomy
have become more widely used [13,14]. With the
development of our experience and skills, laparoscopic par-
tial nephrectomy has now been the first-line therapy for
renal carcinoma at our center if indications are appropriate.
According to our experience, active surveillance or
aspiration biopsy should be performed on suspected
cystic renal masses <3 cm in diameter. CRCC should be
considered if the capsule walls thicken rapidly or if the
contents of the cyst change. If the size of the cystic renal
lesions is >3 cm or if the imaging characteristics do not
meet the performance of renal cysts, surgical exploration is
needed. Intraoperative pathological examination may facili-
tate accurate diagnosis and help clinicians develop further
surgical approaches. However, a few cases with CRCC do
not show any malignant signs. In our study, one ‘simple
renal cyst’ case was diagnosed as CRCC and the patient
underwent open radical nephrectomy 1 month later. For
patients unsuitable for surgery, renal artery embolism,
radiofrequency ablation, immunotherapy, molecular target
therapy, and radiotherapy can be considered. However, the
exact effect remains controversial.
Prognosis of CRCC
CRCC has better prognosis due to low nuclear grade and
TNM stage, regardless of tumor size [16]. The 10-year
survival rates and non-recurrence rate after operation were
97.3% and 90.3%, respectively [17]. Although there are no
specific guidelines, a follow-up every 6 months during the
initial 3 years and then every 1 year is suitable.
In the present study, we retrospectively analyzed a series
of patients with CRCC and summarize the pathologic
features, clinical manifestation, imaging characteristics, sur-
gical treatment, and prognosis of CRCC. Our study showed
that most cases of CRCC can be diagnosed and treated
promptly and accurately through the combination of
imaging examinations (B ultrasonography and CT scan)
and intraoperative pathological examination. Nephrectomy
is the first-line therapy. Nephron-sparing surgery should be
preferred for CRCC. The prognosis of CRCC is good after
a successful operation.
Conclusions
CRCC is a special type of renal cell carcinoma. The diagno-
sis and treatment of CRCC are sometimes difficult because
its clinical manifestations and imaging characteristics
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combining imaging examinations (B ultrasonography and
CT scan) with intraoperative pathological examination,
most cases of CRCC can be diagnosed and treated
promptly and accurately. Nephrectomy is the first-line
therapy. Nephron-sparing surgery should be preferred for
CRCC. The prognosis of CRCC is good after a successful
operation.
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